Atara Biotherapeutics Inc
General ticker "ATRA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $87.4M
Atara Biotherapeutics Inc does not follow the US Stock Market performance with the rate: -22.1%.
Estimated limits based on current volatility of 7.9%: low 9.84$, high 11.52$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.02$, 27.95$]
- 2024-12-30 to 2025-12-30 estimated range: [4.63$, 17.65$]
Short-term ATRA quotes
Long-term ATRA plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $8.57MM |
| Operating Expenses | $284.58MM |
| Operating Income | $-276.01MM |
| Non-Operating Income | $-0.10MM |
| Interest Expense | $5.29MM |
| R&D Expense | $224.78MM |
| Income(Loss) | $-276.11MM |
| Taxes | $0.01MM |
| Profit(Loss) | $-276.13MM |
| Stockholders Equity | $-99.23MM |
| Inventory | $9.71MM |
| Assets | $165.50MM |
| Operating Cash Flow | $-192.98MM |
| Capital expenditure | $1.22MM |
| Investing Cash Flow | $123.87MM |
| Financing Cash Flow | $2.01MM |
| Earnings Per Share* | $-65.18 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.